Probucol (Table 2), a cholesterol-lowering drug that causes LQTS, reduces IKs and IKr by decreasing plasma-membrane protein expression, and the addition of LDL almost completely restored probucol-reduced hERG membrane expression193. This evidence concerns the gene KCNH2 and familial long QT syndrome.